Skip to main content
. 2015 Jan 14;9(3):1013–1017. doi: 10.3892/etm.2015.2179

Figure 3.

Figure 3

Changes in the expression levels of miRNA-210 in the CSF and serum of patients with dementia. miRNA-210 expression in the (A) CSF and (B) serum was detected by the reverse transcription-quantitative polymerase chain reaction. Compared with the control group, *P<0.05 and **P<0.01; compared with the MCI group, ##P<0.01. MCI, mild cognitive impairment; AD, Alzheimer’s disease; miRNA-210, microRNA-210; CSF, cerebrospinal fluid.